Coumarins are a class of heterocyclic compounds present in a significant quantity in several plants. The simplest coumarin, a benzene ring fused with a pyran-2-one heterocycle, was first discovered in the 19 th century and since then, due to the synthetic accessibility and the biological properties of its derivatives, has been playing an important role in the Medicinal Chemistry field. In fact, coumarins have been previously described as anticancer, antiviral, anti-inflammatory, antimicrobial, enzymatic inhibitory and antioxidant agents.
Introduction
Before modern medicine, extracts of plants or plants itself were consumed for their medicinal properties in spite of lack of knowledge of its components or active compound. Nevertheless, we always relied on natural sources to cure ailments and diseases, and the study of natural extracts yielded a vast number of commercial available drugs, just by isolating a pharmacologically active compound or by synthesising an active compound through inspiration of a natural product structure. [1] Today we are facing changing demographics, the extension of life expansion lead to a growing number of cases of neurodegenerative diseases. Thus, there is always a need for a new drug that is safe and can ameliorate the symptoms or even treat these diseases.
Three major classes of products found in nature and with great pharmacological interest are the coumarins, chalcones and the resveratrol derivatives. Coumarins and their natural and/or synthetic derivatives are pharmacologically interesting compounds due to their structural diversity, synthetic accessibility and substitution variability. [1, 2] These heterocyclic compounds have already been previously described as anticancer, antiviral, anti-inflammatory, antimicrobial, enzymatic inhibitory and antioxidant agents. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Taking in account the versatility of the coumarin moiety one can thoroughly modify it to best serve one purposes. In this work, our group fused two other classes of natural products onto the coumarin skeleton, the chalcones (figure 1 -A) and the resveratrol derivatives ( figure 1 -B) . We further explored this nucleus by introducing linkers (figure 1 -C and D), giving us a wide variety of naturally inspired compounds. Chalcones are widely spread in fruits, vegetables, edible plants, spices and tea and have been subject of study for their remarkable pharmacological activity. In addition, they are considered to be precursors of flavonoids and isoflavonoids. [19] Resveratrol and its derivatives are present primarily in red wine, skin of red grapes and peanuts and present significant anti-oxidant activity.
Our goal is to combine the structure of these compounds with a coumarin skeleton to All together our group synthesized a total of 16 compounds and performed various assays like mentioned before.
Experimental Chemistry
The chemicals used in the synthesis were supplied by Aldrich and Merck. Melting points were determined using a Reichert Kofler thermopan or in capillary tubes on a Büchi 510 apparatus and are uncorrected. General procedure for the preparation of coumarin-chalcone precursors (1-4) [20] To a solution of 1 mmol of the appropriate β-ketoester and 1 mmol of the correspondent salicylaldehyde in ethanol (EtOH), in a round bottom flask with a flux of argon at reflux, was added catalytic amounts of piperidine. The reaction mixture was then stirred for 2-5 h. After completion the obtained precipitate was filtered off, washed with cold EtOH and purified by recrystallization with dichloromethane/methanol mixture to give the desired product (scheme 1).
General procedure for the preparation of hydroxylated coumarin-chalcone derivatives (5-8) [20] To 1 mmol of the corresponding methoxy-3-benzoylcoumarin, General procedure for the preparation of 3-amidocoumarin derivatives (12-16) [21] To a solution of 3-aminocoumarin (1 mmol) and pyridine (1.1 mmol) in dichloromethane (9 mL), the corresponding acid chloride (1.1 mmol) was added dropwise and the reaction was stirred, at room temperature, for 3 hours. The solvent was evaporated under vacuum and the dry residue was purified by FC (hexane/ethyl acetate 9:1) (Scheme 2 -B). 
274-275 46%
N-(coumarin-3-yl)benzamide (13) Ref. [16] --4-methoxy-N-(coumarin-3-yl)benzamide (14) Ref. [16] -- 
187-188 80%
4-chloro-N-(coumarin-3-yl)benzamide (16) Ref. [16] --
Pharmacology: AChE and BuChE inhibition
In 96-well plates, the sample was dissolved in phosphate buffer (8 mM K 2 HPO 4 , 2.3 mM NaH 2 PO 4 , 150 mM NaCl, and 0.05% Tween 20 at pH 7.6) and an AChE/BuChE solution (50 μL, 0.25 unit/mL) from Electroporus electricus and equine serum, respectively, in the same phosphate buffer, was added. The assay solutions, except substrate, were pre-incubated with the enzyme for 30 min at room temperature. After pre-incubation, the substrate was added. The substrate solution consists of Na 2 HPO 4 (40 mM), acetylthiocholine/butyrylthiocholine (0.24 mM) and 5,5′-dithio-bis-(2-nitrobenzoic acid) (0.2 mM, DTNB, Ellman's reagent). Absorbance of the yellow anion product, due to the spontaneous hydrolysis of substrate, was measured at 405 nm for 5 min on a microtiter plate reader (Multiskan EX, Thermo, Vantaa, Finland). The AChE/BuChE inhibition was determined for each compound. The enzyme activity was calculated as a percentage compared to a control using only the buffer and enzyme solution. The compounds were assayed in the dilution interval of 500 to 15 μg/mL, and the alkaloid galanthamine was used as the reference compound. Each assay was run in triplicate and each reaction was repeated at least three independent times. The IC 50 values were calculated by means of regression analysis.
[21]
Pharmacology: MAO-A and MAO-B inhibition
Briefly, 0. Control experiments were carried out simultaneously by replacing the test drugs (new compounds and reference inhibitors) with appropriate dilutions of the vehicles. In addition, the possible capacity of the above test drugs to modify the fluorescence generated in the reaction mixture due to non-enzymatic inhibition (e.g., for directly reacting with Amplex Red reagent) was determined by adding these drugs to solutions containing only the Amplex Red reagent in a sodium phosphate buffer.
To determine the kinetic parameters of hMAO-A and hMAO-B (K m and V max ), the corresponding enzymatic activity of both isoforms was evaluated (under the experimental conditions described above) in presence of a number (a wide range) of ptyramine concentrations.
The specific fluorescence emission (used to obtain the final results) was calculated after subtraction of the background activity, which was determined from vials containing all components except the MAO isoforms, which were replaced by a sodium phosphate buffer solution.
Pharmacology: anti-oxidant activity
To the corresponding coumarin−chalcone hybrid compound (1. AUCNET corresponding to the sample was calculated by subtracting the AUC corresponding to the blank. Data processing was performed using Origin Pro 8 SR2
(Origin Lab Corporation). Antioxidant Reactivity by ESR Assay. The reactivity of all coumarin−chalcone hybrids against hydroxyl radicals was assessed using the noncatalytic Fenton method that was previously described.56 In a typical experiment, 150 μL of dimethyl sulfoxide was mixed with 50 μL of NaOH (3 mM) followed by the addition of 50 μL of DMPO (30 mM) spin trap and 50 μL of hydrogen peroxide (30%).
All derivatives were studied at a 4 mM final concentration and a 300 μL final volume.
The mixture was positioned in the ESR cell, and the spectra were recorded after 5 min of the reaction.
Pharmacology: cytotoxicity and cytoprotection assays
Cytotoxicity assays in BAEC cells were performed for all coumarin−chalcone hybrids using the MTT reduction assay. BAEC were seeded in 24-well plates at a density ranging between 104 −105 cells/mL per well. After the cells reached 60−70% confluence, they were incubated in the presence of 10 to 50 μM of the corresponding coumarin−chalcone derivatives for 24 h. After incubation, the medium was changed (2 mL) and 45 μL of a solution of MTT (5 mg/mL in DMEM supplemented with 0.5% FBS) was added to each well. The cells were incubated for another 2 h at 37 °C. The medium was then removed, and the wells were rinsed once with PBS. DMSO (0.6 mL) was added to each well at room temperature to solubilize the formazan crystals. The dissolved formazan was then transferred into 96-well culture plates, and the absorbance was measured at 570 nm using a UV-vis spectrometer. The percent of inhibition of cell viability was calculated using eq 2 percent inhibition (1 / 100) = − A A t s (2) After incubation, the cells were washed with 1× PBS twice to remove the residual drug and exposed to 1 mM of H 2 O 2 and 500 μM of SIN-1 for 2 h and 4 h, respectively. These time periods were chosen on the basis of the observed cell death (>50%) using the H 2 O 2 and SIN-1 concentrations mentioned above. Finally, cell viability was evaluated by the MTT reduction assay and calculated using eq 2. Statistical Analysis. The experimental results are expressed as the mean ± standard error of the mean (SEM) and are accompanied by the number (n) of observations. The differences between the groups were analyzed by student's t test.
Results and Discussion
In the present work we exploit the synthesis and pharmacological activity of a series of coumarin derivatives ( figure 1 ). With the aim to mimic some of the structural functions of already natural products, we explored the importance of the nature of different spacers in the position 3 of the coumarin scaffold and some small groups (methyl, methoxy, hydroxyl, bromo and chloro) attached to the benzenic ring. Our coumarin derivatives 1-16 were efficiently synthesized and characterized (Table 1) . We started from the commercially available products, and obtained different derivatives in moderate to excellent yields. Our compounds were tested according the protocols previously reported, and we achieved promising results. In this paper we present some of those results (table 2, 3 and 4). 
Conclusions
In this work, we describe the synthesis of different scaffolds of natural-hybrid compounds by employing different reactions settings. We successfully obtained 16 compounds in good to excellent yields. The electrochemical properties of the studied compounds proved to be excellent, presenting low oxidation potentials, very high ORAC values (higher than the reference compounds quercetin and catechin), and a high percentage of radical scavenging. The compounds presented low cytotoxicity for BAEC in culture, mainly compound 6 with 93% cell viability in the highest concentration tested.
With the enzymatic inhibition assays we could determine the IC 50 values of our compounds and found that compound 13 is selective for MAO-B and has the best IC 50 of all the compounds tested. However, the interesting part is that some compounds were found to have dual activity against both MAO-B and AChE, making them potential candidates to a lead compound and a more thorough future study.
